Sustained virologic response following HCV eradication in two brothers with X-linked agammaglobulinaemia

World Journal of Gastroenterology

Volumn 15, Issue 31, 2009, Pages 3944-3946

  Houlihan, Diarmaid D ^a   Storan, Eoin R ^a   Lee, John M ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Cirrhosis; Hepatitis C virus; Hepatocellular carcinoma; Immunodeficiency; Viral hepatitis; X linked agammaglobulinaemia

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ADULT; AGAMMAGLOBULINEMIA; ARTICLE; BLOOD; CASE REPORT; COMORBIDITY; DRUG CONTAMINATION; GENETICS; HEPATITIS C; HUMAN; MALE; RECURRENT DISEASE; SIBLING; VIROLOGY; X CHROMOSOME LINKED DISORDER;

ADULT; AGAMMAGLOBULINEMIA; ANTIVIRAL AGENTS; COMORBIDITY; DRUG CONTAMINATION; GENETIC DISEASES, X-LINKED; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; RECURRENCE; RIBAVIRIN; SIBLINGS;

EID: 70350511846     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3944     Document Type: Article

References (16)

1. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, Kruska L, Hensel F, Petry W, Haussinger D. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28: 1687-1695 (Pubitemid 28549142)
2. Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Croce LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999; 44: 874-880 (Pubitemid 29244226)
3. Kumar A, Teuber SS, Gershwin ME. Current perspectives on primary immunodeficiency diseases. Clin Dev Immunol 2006; 13: 223-259 (Pubitemid 44950040)
4. Conley ME. B cells in patients with X-linked agammaglobulinemia. J Immunol 1985; 134: 3070-3074
5. Rozynska KE, Spickett GP, Millrain M, Edwards A, Bryant A, Webster AD, Farrant J. Accessory and T cell defects in acquired and inherited hypogammaglobulinaemia. Clin Exp Immunol 1989; 78: 1-6 (Pubitemid 19256135)
6. Thomson BJ, Doran M, Lever AM, Webster AD. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1987; 1: 539-541
7. Bjorkander J, Cunningham-Rundles C, Lundin P, Olsson R, Soderstrom R, Hanson LA. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988; 84: 107-111 (Pubitemid 18105820)
8. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607-1611 (Pubitemid 24372058)
9. Jonas MM, Baron MJ, Bresee JS, Schneider LC. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics 1996; 98: 211-215 (Pubitemid 26262132)
10. Quinti I, Pierdominici M, Marziali M, Giovannetti A, Donnanno S, Chapel H, Bjorkander J, Aiuti F. European surveillance of immunoglobulin safety-results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Clin Immunol 2002; 104: 231-236 (Pubitemid 35191098)
11. Rossi G, Tucci A, Cariani E, Ravaggi A, Rossini A, Radaeli E. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 1997; 90: 1309-1314 (Pubitemid 27314170)
12. Quinti I, Pandolfi F, Paganelli R, el Salman D, Giovannetti A, Rosso R, Oliva A, Rainaldi L, Aiuti F. HCV infection in patients with primary defects of immunoglobulin production. Clin Exp Immunol 1995; 102: 11-16
13. Christie JM, Healey CJ, Watson J, Wong VS, Duddridge M, Snowden N, Rosenberg WM, Fleming KA, Chapel H, Chapman RW. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin Exp Immunol 1997; 110: 4-8 (Pubitemid 27428507)
14. Bjoro K, Skaug K, Haaland T, Froland SS. Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM 1999; 92: 433-441 (Pubitemid 29385288)
15. Razvi S, Schneider L, Jonas MM, Cunningham-Rundles C. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin Immunol 2001; 101: 284-288 (Pubitemid 33145011)
16. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697-698